Stable economic growth and rising incomes are supporting continued increases in private spending, while governments’ attempts to expand coverage are creating opportunities (marked by pricing pressures) for companies tapping into public spending.
This session by DuckerFrontier will present key economic trends, political developments, and policy initiatives in the ASEAN-5 countries (Indonesia, Malaysia, the Philippines, Thailand, and Vietnam) and highlight their impact on the healthcare industry in the region.
Martin-Immanuel Bittner MD DPhil, Co-Founder & CEO of Arctoris will address how collective efforts combining robotics and AI enable the emergence of a new model of data-driven drug discovery. Bringing together recent advances in life sciences automation and machine learning applications for drug discovery, new partnerships evolve that allow for game-changing improvements in the drug discovery process going beyond what is currently possible.
The country’s growth trajectory—and hence its healthcare spending outlook—will depend heavily on the government’s ability and willingness to implement difficult reforms.
In this session, DuckerFrontier will lead an interactive workshop on how potential scenarios for India’s economic growth will impact healthcare companies operating in the country.